← Back to Clinical Trials
Recruiting NCT07329400

NCT07329400 Turkish Adaptation and Validation of the Burnt Hand Outcome Tool (BHOT)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07329400
Status Recruiting
Phase
Sponsor Necmettin Erbakan University
Condition Hand Burn
Study Type OBSERVATIONAL
Enrollment 100 participants
Start Date 2025-11-17
Primary Completion 2026-04

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Burnt Hand Outcome Tool (BHOT) - Turkish Version

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 100 participants in total. It began in 2025-11-17 with a primary completion date of 2026-04.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this observational study is to evaluate the validity and reliability of the Turkish adaptation of the Burnt Hand Outcome Tool (BHOT) in adults with a history of hand burns. The participant population will include adults aged 18 years and older who have experienced unilateral or bilateral hand burns and can read and understand Turkish.The main questions this study aims to answer are: Does the Turkish version of the BHOT demonstrate high internal consistency, test-retest reliability, and construct validity? How strongly are BHOT scores associated with objective hand function measures such as grip strength and sensory evaluation? Participants will not be assigned to comparison groups, as this is a methodological validation study. Participants will: Complete a sociodemographic information form. Complete the Turkish version of the BHOT and the QuickDASH questionnaire. Undergo objective assessments including hand grip strength using a dynamometer and sensory evaluation using Semmes-Weinstein monofilaments. Participate in repeated assessments at baseline, 1 month, 3 months and 6 months for reliability analyses.

Eligibility Criteria

Inclusion Criteria: * Age 18 years or older * History of second-degree or higher burn injury in one or both hands * Ability to read and understand Turkish * Willingness to participate and provision of written informed consent Exclusion Criteria: * History of trauma, surgery, or rheumatologic disease affecting hand function prior to the burn injury * Age under 18 years * Cognitive impairment or psychiatric disorder preventing completion of the questionnaires * Refusal to participate or withdrawal from the study at any time

Contact & Investigator

Central Contact

Pariya Puriyamanesh

✉ fzt.pariya@gmail.com

📞 +905538304970

Frequently Asked Questions

Who can join the NCT07329400 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Hand Burn. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07329400 currently recruiting?

Yes, NCT07329400 is actively recruiting participants. Contact the research team at fzt.pariya@gmail.com for enrollment information.

Where is the NCT07329400 trial being conducted?

This trial is being conducted at Konya, Turkey (Türkiye).

Who is sponsoring the NCT07329400 clinical trial?

NCT07329400 is sponsored by Necmettin Erbakan University. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology